Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | BRAF | P15056 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9139120 | 0.87 | NPC1 (0.42) | NPC1RAB9AKDM4EALDH1A1KMT2A | |
| SCHEMBL2429665 | 0.82 | NPC1 (0.45) | NPC1RAB9AKDM4EALDH1A1KMT2A | |
| SCHEMBL29045209 | 0.72 | NPC1 (0.40) | NPC1RAB9AKDM4EALDH1A1KMT2A | |
| SCHEMBL5317101 | 0.72 | — | — | |
| SCHEMBL262815 | 0.72 | — | — | |
| SCHEMBL27352543 | 0.72 | — | — | |
| Imidazole SCHEMBL28321978 | 0.72 | NPC1 (0.38) | NPC1RAB9AKDM4EALDH1A1KMT2A | |
| SCHEMBL31229951 | 0.72 | NPC1 (0.47) | NPC1RAB9AKDM4EALDH1A1KMT2A | |
| SCHEMBL152733 | 0.71 | NUDT1 (0.49) | NPC1RAB9AKDM4EALDH1A1KMT2A | |
| SCHEMBL28554259 | 0.70 | NPC1 (0.44) | NPC1RAB9AKDM4EALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1931662-A1 | PYRIMIDINE DERIVATIVES FOR THE INHIBITION OF IGF-IR TYROSINE KINASE ACTIVITY | AstraZeneca AB (SE) | 2008-06-18 | — | — | EP | disclosed |
| WO-2007031745-A1 | PYRIMIDINE DERIVATIVES FOR THE INHIBITION OF IGF-IR TYROSINE KINASE ACTIVITY | ASTRAZENECA AB (SE) | 2007-03-22 | — | — | WO | disclosed |